GTx says muscle loss drug successful in study
Monday, June 21st, 2010
Biotechnology company GTx Inc. said Monday its potential muscle loss drug met key goals in a 12-week study on postmenopausal women.
Posts Tagged ‘Biotechnology Company’
Genzyme gets FDA approval for Lumizyme
Tuesday, May 25th, 2010
Federal regulators approved Genzyme's drug to treat a muscle development disease, sending shares of the Biotechnology company up 6 percent Tuesday.
RXi Pharma signs development deal with miRagen
Monday, April 12th, 2010
Biotechnology company RXi Pharmaceuticals Corp. said Monday it is collaborating with miRagen Therapeutics Inc. to develop potential treatments for heart and bmuscle/b diseases. Financial terms of the deal were not disclosed.
How to Protect Against the Swine Flu Virus with Gene-Eden, an Antiviral Natural Supplement
Tuesday, October 6th, 2009
by Mark B. Finnely On September 21, 2009, the Center for the biology of chronic disease (CBCD) announced in a press release that Gene-Eden, an antiviral nutritional supplement researched, developed and marketed by polyDNA, may be effective against the swine flu (H1N1) virus. polyDNA is a biotechnology company specializing in researching, developing, and marketing science-based nutritional supplements. Gene-Eden, is an all natural, antiviral supplement that targets many viruses during their chr
Customer Testimonial: How I Stopped the Swine Flu Virus with Gene-Eden, Natural, Broad range, Antiviral Supplement
Saturday, October 3rd, 2009
by Mark T. Johnson On September 21, 2009, the Center for the biology of chronic disease (CBCD) announced in a press release that Gene-Eden, an antiviral nutritional supplement researched, developed and marketed by polyDNA, may be effective against the swine flu (H1N1) virus. polyDNA is a biotechnology company specializing in researching, developing, and marketing science-based nutritional supplements. Gene-Eden, is an all natural, antiviral supplement that targets many viruses during their chr